| |
 |
ARTICLES 
|
|
| Angiogenesis and breast cancer |
| J Folkman |
|
JCO Mar 1 1994: 441–443.
[PDF]
|
 |
| Postmastectomy radiotherapy: more than locoregional control |
| LJ Pierce and AS Lichter |
|
JCO Mar 1 1994: 444–446.
[PDF]
|
|
|
Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy |
| |
J Cuzick, H Stewart, L Rutqvist, J Houghton, R Edwards, C Redmond, R Peto, M Baum, B Fisher, and H Host |
| |
JCO Mar 1 1994: 447–453.
[Abstract]
[PDF]
|
|
|
Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node- negative breast carcinoma |
| |
G Gasparini, N Weidner, P Bevilacqua, S Maluta, P Dalla Palma, O Caffo, M Barbareschi, P Boracchi, E Marubini, and F Pozza |
| |
JCO Mar 1 1994: 454–466.
[Abstract]
[PDF]
|
|
|
Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer |
| |
PM Ravdin, AK Tandon, DC Allred, GM Clark, SA Fuqua, SH Hilsenbeck, GC Chamness, and CK Osborne |
| |
JCO Mar 1 1994: 467–474.
[Abstract]
[PDF]
|
|
|
Sensitive detection of occult breast cancer by the reverse- transcriptase polymerase chain reaction |
| |
YH Datta, PT Adams, WR Drobyski, SP Ethier, VH Terry, and MS Roth |
| |
JCO Mar 1 1994: 475–482.
[Abstract]
[PDF]
|
|
|
Escalated dosages of methotrexate, vinblastine, doxorubicin, and cisplatin plus recombinant human granulocyte colony-stimulating factor in advanced urothelial carcinoma: an Eastern Cooperative Oncology Group trial |
| |
Sr Loehrer PJ, P Elson, R Dreicer, R Hahn, CR Nichols, R Williams, and LH Einhorn |
| |
JCO Mar 1 1994: 483–488.
[Abstract]
[PDF]
|
|
|
Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels |
| |
YZ Patt, DA Podoloff, S Curley, L Kasi, R Smith, V Bhadkamkar, and C Charnsangavej |
| |
JCO Mar 1 1994: 489–495.
[Abstract]
[PDF]
|
|
|
Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy |
| |
V Liengswangwong, JA Bonner, EG Shaw, RL Foote, S Frytak, RT Eagan, JR Jett, RL Richardson, ET Creagan, and JQ Su |
| |
JCO Mar 1 1994: 496–502.
[Abstract]
[PDF]
|
|
|
High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma |
| |
AM Gianni, C Tarella, M Bregni, S Siena, F Lombardi, L Gandola, D Caracciolo, A Stern, G Bonadonna, and M Boccadoro |
| |
JCO Mar 1 1994: 503–509.
[Abstract]
[PDF]
|
|
|
Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis |
| |
BW Corn, RM Lanciano, KM Greven, J Noumoff, D Schultz, GE Hanks, and BL Fowble |
| |
JCO Mar 1 1994: 510–515.
[Abstract]
[PDF]
|
|
|
Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 Study |
| |
P Rousseau, F Flamant, E Quintana, PA Voute, and JC Gentet |
| |
JCO Mar 1 1994: 516–521.
[Abstract]
[PDF]
|
|
|
Dose-intensive cyclophosphamide with etoposide and vincristine for pediatric solid tumors: a phase I/II pilot study by the Australia and New Zealand Childhood Cancer Study Group |
| |
L White, G McCowage, G Kannourakis, V Nayanar, L Colnan, S Kellie, P Shaw, R Seshadri, L Lockwood, and K Tiedemann |
| |
JCO Mar 1 1994: 522–531.
[Abstract]
[PDF]
|
|
|
Saturable pharmacokinetics and paclitaxel pharmacodynamics in children with solid tumors |
| |
DS Sonnichsen, CA Hurwitz, CB Pratt, JJ Shuster, and MV Relling |
| |
JCO Mar 1 1994: 532–538.
[Abstract]
[PDF]
|
|
|
Phase I study of topotecan for pediatric patients with malignant solid tumors |
| |
CB Pratt, C Stewart, VM Santana, L Bowman, W Furman, J Ochs, N Marina, JF Kuttesch, R Heideman, and JT Sandlund |
| |
JCO Mar 1 1994: 539–543.
[Abstract]
[PDF]
|
|
|
Ifosfamide, carboplatin, and etoposide: a new regimen with a broad spectrum of activity |
| |
KK Fields, PE Zorsky, JW Hiemenz, LE Kronish, and GJ Elfenbein |
| |
JCO Mar 1 1994: 544–552.
[Abstract]
[PDF]
|
|
|
Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen |
| |
H Hochster, L Liebes, J Speyer, J Sorich, B Taubes, R Oratz, J Wernz, A Chachoua, B Raphael, and RZ Vinci |
| |
JCO Mar 1 1994: 553–559.
[Abstract]
[PDF]
|
|
|
Phase I and pharmacokinetic study of recombinant human granulocyte- macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinoma |
| |
JL Grem, N McAtee, RF Murphy, JM Hamilton, F Balis, S Steinberg, SG Arbuck, A Setser, E Jordan, and A Chen |
| |
JCO Mar 1 1994: 560–568.
[Abstract]
[PDF]
|
|
|
Phase I study of combined 2-chlorodeoxyadenosine and chlorambucil in chronic lymphoid leukemia and low-grade lymphoma |
| |
A Tefferi, TE Witzig, JM Reid, CY Li, and MM Ames |
| |
JCO Mar 1 1994: 569–574.
[Abstract]
[PDF]
|
|
|
Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma |
| |
P McLaughlin, FB Hagemeister, F Swan, Jr, F Cabanillas, O Pate, JE Romaguera, MA Rodriguez, JR Redman, and M Keating |
| |
JCO Mar 1 1994: 575–579.
[Abstract]
[PDF]
|
|
|
Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group |
| |
MG Pfreundschuh, U Rueffer, B Lathan, N Schmitz, O Brosteanu, D Hasenclever, R Haas, H Kirchner, P Koch, and R Kuse |
| |
JCO Mar 1 1994: 580–586.
[Abstract]
[PDF]
|
|
|
High-dose mercaptopurine followed by intermediate-dose cytarabine in relapsed acute leukemia |
| |
S Lockhart, W Plunkett, S Jeha, I Ramirez, T Zipf, A Cork, and D Pinkel |
| |
JCO Mar 1 1994: 587–595.
[Abstract]
[PDF]
|
|
|
A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis |
| |
PJ Hesketh, WH Harvey, WG Harker, TM Beck, T Ryan, LJ Bricker, JA Kish, WK Murphy, JD Hainsworth, and B Haley |
| |
JCO Mar 1 1994: 596–600.
[Abstract]
[PDF]
|
|
|
Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group |
| |
CL Loprinzi, JA Laurie, HS Wieand, JE Krook, PJ Novotny, JW Kugler, J Bartel, M Law, M Bateman, and NE Klatt |
| |
JCO Mar 1 1994: 601–607.
[Abstract]
[PDF]
|
|
|
Lessons learned from measuring health-related quality of life in oncology |
| |
D Osoba |
| |
JCO Mar 1 1994: 608–616.
[Abstract]
[PDF]
|
|
|
Tamoxifen: is it useful in the treatment of patients with metastatic melanoma? |
| |
EF McClay and ME McClay |
| |
JCO Mar 1 1994: 617–626.
[Abstract]
[PDF]
|
|
|
Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy |
| |
JR Crossen, D Garwood, E Glatstein, and EA Neuwelt |
| |
JCO Mar 1 1994: 627–642.
[Abstract]
[PDF]
|
|
| Thoracic radiotherapy and chemotherapy for small-cell lung cancer: the discussion continues |
| JS Tobias and SG Spiro |
|
JCO Mar 1 1994: 643–644.
[PDF]
|
|
| The importance of bleomycin in combination chemotherapy for good- prognosis germ cell carcinoma |
| G Stoter, SB Kaye, PH de Mulder, J Levi, and D Raghavan |
|
JCO Mar 1 1994: 644–645.
[PDF]
|
|
| Liposomal-doxorubicin in human immunodeficiency virus-associated Kaposi's sarcoma |
| I Poizot-Martin, M Giovannini, R Rosello, JR Viallat, JF Sauniere, AM Dalmas, D Genre, C Dhiver, and JA Gastaut |
|
JCO Mar 1 1994: 645.
[PDF]
|
|
